JPRN-jRCT1050220063招募中1 期
Efficacy and safety of hemodilutional autologous blood transfusion for intermediate- to advanced- liver resection
chida Yoichiro0 个研究点目标入组 50 人开始时间: 2022年7月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. More than 18 years
- •2. All disease which would be required for hepatectomy
- •3. intermediate-to-difficult hepatectomy
- •4. HAT cases
排除标准
- •1. Hepatectomy with concomitant some surgery (e.g., gastrectomy or pancreaticoduodenecrtomy)
- •2. Donor hepatectomy
研究者
相似试验
招募中
2 期
Autologous Haematopoietic Stem Cell Transplantation for highly active treatment resistant multiple sclerosis.ACTRN12619000348156Alfred Health50
招募中
不适用
Evaluation of efficacy and safety of autologous bone marrow mesenchymal stem cells for traumatic spinal cord injury: Use-results comparative surveySpinal Cord InjuryJPRN-jRCT2053210130Room Stemirac Information612
招募中
1 期
The safety and efficacy of autologous peripheral blood mononuclear cell ex vivo culture amplified cells (MNC-QQ) for alopecia: Phase 1 / 2 clinical studyAlopeciaJPRN-jRCTb030230286Ikeda Yoshio5
尚未招募
1 期
Safety and clinical effectiveness of autologous mesenchymal stromal cell infusion as adjuncttreatment in patients with Idiopathic Pulmonary FibrosisJ84.1Other interstitial pulmonary diseases with fibrosisDRKS00008790The Republican Research and Practical Centre for Pulmonology and TB40
已完成
不适用
Efficacy and Safety Profile of Autologous Blood Versus Talc Pleurodesis for Malignant Pleural EffusioSymptomatic malignant pleural effusion patientsPleurodesis,Autologous blood,Talc,Malignant pleural effusion,MPE,EfficacyTCTR20150717001Human Research Ethic Committee108